Open study of quadrivalent VN-100 in healthy children
Phase of Trial: Phase III
Latest Information Update: 08 Jun 2016
At a glance
- Drugs Influenza A virus vaccine-H5N1 (Primary)
- Indications Influenza virus infections
- Focus Pharmacodynamics
- Sponsors Daiichi Sankyo Company; Japan Vaccine; Kitasato Daiichi Sankyo Vaccine; Terumo
- 08 Jun 2016 New trial record
- 31 Mar 2016 Status changed from not yet recruiting to active, no longer recruiting.
- 01 Oct 2015 Status changed from active, no longer recruiting to completed.